GlassScriptPhysician profile
Kevin Eugene Jefferson
NPI 1811080229
$94,387.33
in general payments reported to CMS, 2019-2025
16 companies · $2,260 in 2025
The $2,260 reported for 2025 was more than what 91% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $181 · 2021: $288 · 2022: $2,657 · 2023: $74.06 · 2024: $89K · 2025: $2,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $87K · Travel and Lodging: $2,600 · Food and Beverage: $1,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $87,200.00 |
| Travel and Lodging | $2,600.06 |
| Food and Beverage | $1,126.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $87,243.85 | 2024-2025 | |
| Triad Life Sciences INC. | $2,428.95 | 2022 | |
| Lifenet Health | $2,253.17 | 2024-2025 | Theragenesis Wound Matrix |
| Smith+Nephew, INC. | $857.18 | 2019-2025 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Treace Medical Concepts, INC. | $843.09 | 2025 | |
| Paratek Pharmaceuticals, INC. | $324.74 | 2021-2025 | Nuzyra |
| Glaxosmithkline, LLC. | $116.39 | 2024 | Nucala |
| Organogenesis INC. | $67.65 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $61.31 | 2023 | Stratum Foot Plating System |
| Supreme Orthopedic Systems, LLC | $44.51 | 2025 | |
| Baxter Healthcare | $32.50 | 2024 | Tisseel |
| Amgen INC. | $28.92 | 2025 | Krystexxa |
| Horizon Therapeutics Plc | $26.47 | 2019-2021 | |
| Averitas Pharma INC. | $20.94 | 2025 | Qutenza |
| Novum Pharma, LLC | $20.65 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $17.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Jefferson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.